[1] 崔立强. 中国大陆地区股骨头坏死病因学调查及危险因素初步分析[D].北京:北京协和医学院,2014.
[2] SONG L, ZHANG S.Anti-aging activity and modes of action of compounds from natural food sources. Biomolecules. 2023;13(11): 1600.
[3] SHI T, LIU T, KOU Y, et al. The synergistic effect of Zuogui Pill and Eldecalcitol on improving bone mass and osteogenesis in type 2 diabetic osteoporosis. Medicina (Kaunas). 2023;59(8):1414.
[4] LI P, XU TY, YU AX, et al. The role of ferroptosis in osteoporosis and advances in Chinese herbal interventions. Biology. 2025;14(4):367.
[5] LI Q, TIAN C, LIU X, et al. Anti-inflammatory and antioxidant traditional Chinese medicine in treatment and prevention of osteoporosis. Front Pharmacol. 2023;14:1203767.
[6] 卓小霞, 段宏婷, 闫媛聪, 等. 菟丝子中黄酮类成分的生物活性及体内代谢的研究进展[J]. 华西药学杂志,2023,38(6):705-710.
[7] 陈鲁宁, 胡扬, 辛国松, 等. 菟丝子化学成分、药理作用研究进展及其质量标志物(Q-Marker)预测[J]. 中草药,2024,55(15):5298-5314.
[8] WEI S, MA W, XIE S, et al. Hyperoside protects trastuzumab-induced cardiotoxicity via activating the PI3K/Akt signaling pathway. Cardiovasc Drugs Ther. 2025;39(3):481-490.
[9] HE J, LI X, WANG Z, et al. Therapeutic anabolic and anticatabolic benefits of natural Chinese medicines for the treatment of osteoporosis. Front Pharmacol. 2019;10:1344.
[10] 李泰贤, 陈志伟, 王荣田, 等. 基于文献计量学分析中医药治疗股骨头坏死的研究现状[J].中国中医骨伤科杂志,2017,25(4):41-46.
[11] 刘亚芳, 刘毅, 丁婉悦, 等. 菟丝子补肾药理作用研究进展[J]. 宜春学院学报,2021,43(9):22-25.
[12] 王莹, 张婧如, 田伟, 等. 菟丝子及其提取物药理机制研究进展 [J]. 中国中医基础医学杂志,2023,29(11):1961-1964.
[13] DUAN Y, SU YT, REN J, et al. Kidney tonifying traditional Chinese medicine: Potential implications for the prevention and treatment of osteoporosiss. Front Pharmacol. 2023;13:1063899.
[14] 徐何方, 杨颂, 李莎莎,等. 菟丝子醇提物对肾阳虚证模型大鼠免疫功能的影响[J]. 中药材,2015,38(10):2163-2165.
[15] 孟晓彤, 廖礼彬, 马伊萱, 等. 菟丝子黄酮对少弱精子症大鼠睾丸GM-CSF表达的影响[J]. 中华男科学杂志,2020,26(7):639-644.
[16] 赵宝宝, 李兴勇, 董万涛, 等. 中药菟丝子防治骨质疏松症的研究进展[J]. 中国骨质疏松杂志,2023,29(7):1089-1092.
[17] FAN S, PAN H, HUANG J, et al. Hyperoside exerts osteoprotective effect on dexamethasone-induced osteoblasts by targeting NADPH Oxidase 4 (NOX4) to inhibit the reactive oxygen species (ROS) accumulation and activate c-Jun N-terminal kinase (JNK) pathway. Bioengineered. 2022;13(4):8657-8666.
[18] CAO G, HU SQ, NING Y, et al. Traditional Chinese medicine in osteoporosis: from pathogenesis to potential activity. Front Pharmacol. 2024;15(000):18.
[19] TAN M, LI Q, YANG B, et al. Insight of Chinese herbal medicine in treating osteoporosis: Achievements from 2013 to 2023. Am J Chin Med. 2024;52(5):26.
[20] WANG G, ZHANG L, YAN C, et al. Upregulation of microRNA-576-5p protects from steroid-induced avascular necrosis of the femoral head by suppressing ANXA2. Cell Cycle. 2022;21(1):49-62.
[21] CAI T, CHEN S, WU C, et al. Erythropoietin suppresses osteoblast apoptosis and ameliorates steroid-induced necrosis of the femoral head in rats by inhibition of STAT1-caspase 3 signaling pathway. BMC Musculoskelet Disord. 2023;24(1):894.
[22] JIANG M, ZHANG K, HU Y, et al. The IFT80/Hedgehog pathway regulates the osteogenic-adipogenic differentiation of bone marrow mesenchymal stem cells. Curr Med Chem. 2024. doi: 10.2174/0109298673300113240418050128.
[23] CAO J, LI Y, SI M, et al. Kaempferol combats the osteogenic differentiation damage of periodontal ligament stem cells in periodontitis via regulating EphrinB2-mediated PI3K/Akt and P38 pathways. Phytomedicine. 2025;141:157002.
[24] 丘博元, 刘飞, 童思文, 等. 激素性股骨头坏死衰老关键基因的生物信息学鉴定和验证[J].中国组织工程研究,2025,29(26):5608-5620.
[25] KUAI J, ZHENG J, KUMAR A, et al. Anti-inflammatory, antiosteoporotic, and bone protective effect of hydroxysafflor yellow A against glucocorticoid-induced osteoporosis in rats. J Biochem Mol Toxicol. 2024;38(9):e23797.
[26] GAO Y, CHEN C, LIU R, et al. Research progress of connexin 43 mediated gap junction communication regulating bone metabolism in glucocorticoid-induced osteonecrosis of the femoral head. Exp Cell Res. 2025;449(1):114598.
[27] YAN Z, ZHAN J, QI W, et al. The protective effect of luteolin in glucocorticoid-induced osteonecrosis of the femoral head. Front Pharmacol. 2020;11:1195.
[28] HUANG C, JIN H, ZHANG Y, et al. Eucommia ulmoides Oliv. and its bioactive compounds: therapeutic potential in bone diseases. Front Pharmacol. 2025;16:1601537.
[29] QIANG S, HAIMING Y, LVLIN Y, et al.Lycium barbarum polysaccharide protects against osteonecrosis of femoral head via regulating Runx2 expression. Injury. 2022;53(4):1361-1367.
[30] 肖阳, 邢涛, 李向洲, 等. 外泌体在激素性股骨头坏死中的作用及中医药干预的研究进展[J]. 西部中医药,2025,38(7):96-102.
[31] HE W, XU C, FAN Y, et al. Effects of the Chinese drugs for activating blood circulation on plasma TXB2 and 6-keto-PGF1alpha contents in rabbits with glucocorticoid-induced femoral head necrosis. J Tradit Chin Med. 2004;24(3):233-237.
[32] 王克忠, 毛林中, 胡朝贵. 激素性股骨头坏死发病机制的实验研究[J].中华外科杂志,1994,32(9):515-517.
[33] LI P, XIE C, LIU Y, et al. Quantitative analysis of local microcirculation changes in early osteonecrosis of femoral head: DCE-MRI findings. Front Surg. 2022;9:1003879.
[34] 魏秋实, 何伟, 张庆文, 等. 股骨头坏死中医证型分布规律的文献研究和系统评价[J].中华关节外科杂志(电子版),2013,7(3):369-372.
[35] WANG WJ, ZHANG XH, WANG RX, et al. Observations on after-effect duration of kidney-nourishing and marrow-replenishing therapy on 58 cases of Mediterranean anemia. J Tradit Chin Med. 2009;29(4):258-262.
[36] 孟娜, 徐双坤, 吕维瑶, 等. 菟丝子黄酮类化合物治疗不孕症的药理机制研究进展[J].环球中医药,2025,18(4):857-862.
[37] 张雨婷, 杨之童, 刘子路, 等. UPLC-MS/MS测定菟丝子不同炮制品中3种黄酮类成分在大鼠体内的药物代谢动力学研究[J]. 安徽中医药大学学报,2025,44(2):100-107.
[38] 马天宇, 史孟华, 林煦垚, 等. 菟丝子治疗男性不育症的作用机制研究进展[J]. 云南中医药大学学报,2025,48(1):106-112.
[39] 刘海云, 纪玉龙, 何志坚. 菟丝子提取物对自然衰老小鼠学习记忆能力及肝和脑组织ATP酶活力的影响 [J]. 中国老年学杂志,2018, 38(23):5794-5796.
[40] HONG XL, ZHAO Z, ZHAO YW, et al. Human mesenchymal stem cells-derived exosome mimetic vesicles regulation of the MAPK pathway and ROS levels inhibits glucocorticoid-induced apoptosis in osteoblasts. Stem Cells Int. 2023;2023:5537610.
[41] 王翔宇, 冯晓云, 任红叶, 等. 菟丝子提取物通过BMP2/Smad4信号通路对MC3T3-E1细胞增殖的影响[J]. 中华中医药杂志,2019, 34(6):2687-2689.
[42] GUO S, MAO L, JI F, et al. Activating AMP-activated protein kinase by an α1 selective activator compound 13 attenuates dexamethasone-induced osteoblast cell death. Biochem Biophys Res Commun. 2016; 471(4):545-552.
[43] JILKA RL, WEINSTEIN RS FAU - PARFITT AM, PARFITT AM FAU - MANOLAGAS SC, et al. Quantifying osteoblast and osteocyte apoptosis: challenges and rewards. J Bone Miner Res. 2007;22(10): 1492-1501.
[44] BAI L, WANG T, ZHENG J, et al. SIRT1 mediated by baicalein and GFI1 promotes osteogenic differentiation and ameliorates osteoporosis by inhibiting ferroptosis in bone marrow mesenchymal stem cells. Biochem Mol Toxicol. 2025;39(7):e70368.
[45] LIU S, FANG T, YANG L, et al. Gastrodin protects MC3T3-E1 osteoblasts from dexamethasone-induced cellular dysfunction and promotes bone formation via induction of the NRF2 signaling pathway. Int J Mol Med. 2018;41(4):2059-2069.
[46] 陈晨, 郑润泉, 李宗玉. miR-218-5p通过靶向下调ANKRD1抑制地塞米松诱导的人成骨细胞HFOB1.19损伤[J]. 中国免疫学杂志, 2022,38(19):2325-2359+2335.
[47] PENG P, WANG X, QIU C, et al. Extracellular vesicles from human umbilical cord mesenchymal stem cells prevent steroid-induced avascular necrosis of the femoral head via the PI3K/AKT pathway. Food Chem Toxicol. 2023;180:114004.
[48] LV W, YU M, YANG Q, et al. Total flavonoids of Rhizoma drynariae ameliorate steroid‑induced avascular necrosis of the femoral head via the PI3K/AKT pathway. Mol Med Rep. 2021;23(5):345.
[49] XUE XH, FENG ZH, LI ZX, et al. Salidroside inhibits steroid-induced avascular necrosis of the femoral head via the PI3K/Akt signaling pathway: In vitro and in vivo studies. Mol Med Rep. 2018;17(3):3751-3757.
[50] YANG N, LI M, LI X, et al. MAGL blockade alleviates steroid-induced femoral head osteonecrosis by reprogramming BMSC fate in rat. Cell Mol Life Sci. 2024;81(1):418.
[51] DENG S, DAI G, CHEN S, et al. Dexamethasone induces osteoblast apoptosis through ROS-PI3K/AKT/GSK3β signaling pathway. Biomed Pharmacother. 2018;110:602-608.
[52] SUN F, ZHOU JL, WEI SX, et al. Glucocorticoids induce osteonecrosis of the femoral head in rats via PI3K/AKT/FOXO1 signaling pathway. PeerJ. 2022;10:e13319.
|